Results 21 to 30 of about 13,568 (269)

The Clinical Utility of Biochemical Biomarkers in Colorectal Cancer [PDF]

open access: yesMiddle East Journal of Cancer
Colorectal cancer (CRC) ranks as the third most prevalent cancer worldwide and is a leading cause of cancer-related mortality. Since many colon cancers present no significant clinical symptoms, identifying new biomarkers or a set of biological indicators
Durdi Qujeq   +5 more
doaj   +1 more source

Structural insights into mechanism and specificity of the plant protein O-fucosyltransferase SPINDLY

open access: yesNature Communications, 2022
Arabidopsis SPINDLY (SPY) is a nucleocytoplasmic protein O-fucosyltransferase. Here, the authors present a crystal structure of Arabidopsis SPY/GDP complex, reveal SPY’s substrate recognition and enzyme mechanism, and provide insights into the glycan ...
Li Zhu   +5 more
doaj   +1 more source

Fucosyltransferase activities in human lymphocytes and granulocytes Blood group H-gene-specified α-2-L-fucosyltransferase is a discriminatory marker of peripheral blood lymphocytes [PDF]

open access: yes, 1983
Human lymphocytes and granulocytes were examined for blood group H-gene-specified α-2-L-fucosyl-transferase, α-3-L-fucosyltransferase and blood group Le-gene-specified α-4-L-fucosyltransferase.
Ball, M.Geraldine   +5 more
core   +1 more source

Determination of α1–6-fucosyltransferase activity. [PDF]

open access: yes, 2014
Recombinant FLAG-tagged Sf9 FUT8 was produced using the baculovirus-Sf9 cell system and purified using anti-FLAG M2 affinity gel. The fucosyltransferase activity of the recombinant protein was tested with GDP-[14C]-L-fucose, as substrate, after two days (
François Monjaret (647590)   +7 more
core   +1 more source

FUT8 Alpha-(1,6)-Fucosyltransferase in Cancer [PDF]

open access: yes, 2021
Aberrant glycosylation is a universal feature of cancer cells that can impact all steps in tumour progression from malignant transformation to metastasis and immune evasion. One key change in tumour glycosylation is altered core fucosylation.
Jennifer Munkley   +3 more
core   +4 more sources

Survey and characterization of nonfunctional alleles of FUT2 in a database

open access: yesScientific Reports, 2021
The expression of ABO antigens in human saliva is regulated by the FUT2 gene, which encodes a secretor type α(1,2)fucosyltransferase. Secretors express ABO substrates in saliva and non-secretors do not. Secretor status is an object of concern, especially
Mikiko Soejima, Yoshiro Koda
doaj   +1 more source

Human platelets release α-6-L-fucosyltransferase upon activation [PDF]

open access: yes, 1989
Previously we have shown that human platelets release α-6-L-fucosyltransferase (EC 2.4.1.68) during coagulation of blood [(1987) Glycoconjugate J. 4, 43–49]. Here we report that agonists which induce platelet aggregation bring about release of the enzyme.
Kościelak, J.   +7 more
core   +1 more source

Evaluation of the Correlation between the Alteration of Specific Biochemical Indicators levels in the Early Stages of Colorectal Cancer

open access: yesمجله دانشگاه علوم پزشکی گرگان, 2021
Background and Objective: Colorectal cancer is one of the most common cancers and considered to be leading causes of cancer death in the world. One of the problems with this type of cancer is its inability to be detected in early stage.
Roya Abbasinatajomrani   +3 more
doaj  

Improved production of 2′-fucosyllactose in engineered Saccharomyces cerevisiae expressing a putative α-1, 2-fucosyltransferase from Bacillus cereus

open access: yesMicrobial Cell Factories, 2021
Background 2′-fucosyllactose (2′-FL) is one of the most abundant oligosaccharides in human milk. It constitutes an authorized functional additive to improve infant nutrition and health in manufactured infant formulations.
Mingyuan Xu   +4 more
doaj   +1 more source

Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftment [PDF]

open access: yesCytotherapy, 2014
Background aims: Advantages associated with the use of cord blood (CB) transplantation include the availability of cryopreserved units, ethnic diversity and lower incidence of graft-versus-host disease compared with bone marrow or mobilized peripheral blood. However, poor engraftment remains a major obstacle.
Robinson, Simon N   +20 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy